Physician profile
Kurt E Treu
NPI 1225146988
$2,326.70
in general payments reported to CMS, 2019-2025
12 companies · $186 in 2025
The $186 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $474 · 2020: $821 · 2021: $150 · 2022: $319 · 2023: $84.81 · 2024: $293 · 2025: $186.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $563.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $563.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $695.80 | 2019-2025 | Clariti Contact Lens, Myday Contact Lens, Misight Contact Lens |
| Alcon Vision LLC | $600.34 | 2019-2025 | Precision7, Total30 |
| Abb Con-Cise Optical Group LLC | $384.22 | 2019-2024 | Spectacle Lenses, Contact Lens |
| Visioneering Technologies, INC. | $241.53 | 2019-2021 | |
| Johnson & Johnson Vision Care, INC. | $109.13 | 2019-2020 | |
| Bausch & Lomb Americas INC. | $91.31 | 2023-2025 | Infuse, Biotrue One Day |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $62.71 | 2020-2021 | |
| Biotissue Holdings INC. | $49.98 | 2019-2025 | |
| Synergeyes, INC. | $45.27 | 2019 | |
| Oyster Point Pharma, INC. | $19.70 | 2022 | |
| Lkc Technologies, INC. | $13.64 | 2024 | |
| Allergan, INC. | $13.07 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kurt Treu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.